Correlation Between OHR Pharmaceutical and SentinelOne
Can any of the company-specific risk be diversified away by investing in both OHR Pharmaceutical and SentinelOne at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OHR Pharmaceutical and SentinelOne into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OHR Pharmaceutical and SentinelOne, you can compare the effects of market volatilities on OHR Pharmaceutical and SentinelOne and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OHR Pharmaceutical with a short position of SentinelOne. Check out your portfolio center. Please also check ongoing floating volatility patterns of OHR Pharmaceutical and SentinelOne.
Diversification Opportunities for OHR Pharmaceutical and SentinelOne
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between OHR and SentinelOne is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding OHR Pharmaceutical and SentinelOne in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SentinelOne and OHR Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OHR Pharmaceutical are associated (or correlated) with SentinelOne. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SentinelOne has no effect on the direction of OHR Pharmaceutical i.e., OHR Pharmaceutical and SentinelOne go up and down completely randomly.
Pair Corralation between OHR Pharmaceutical and SentinelOne
If you would invest (100.00) in OHR Pharmaceutical on January 26, 2024 and sell it today you would earn a total of 100.00 from holding OHR Pharmaceutical or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
OHR Pharmaceutical vs. SentinelOne
Performance |
| Timeline |
| OHR Pharmaceutical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| SentinelOne |
OHR Pharmaceutical and SentinelOne Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OHR Pharmaceutical and SentinelOne
The main advantage of trading using opposite OHR Pharmaceutical and SentinelOne positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OHR Pharmaceutical position performs unexpectedly, SentinelOne can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SentinelOne will offset losses from the drop in SentinelOne's long position.| OHR Pharmaceutical vs. Univest Pennsylvania | OHR Pharmaceutical vs. Sphere Entertainment Co | OHR Pharmaceutical vs. Glacier Bancorp | OHR Pharmaceutical vs. Chiba Bank Ltd |
| SentinelOne vs. Crowdstrike Holdings | SentinelOne vs. Okta Inc | SentinelOne vs. Cloudflare | SentinelOne vs. MongoDB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |